Related Experiment Video
Updated: May 24, 2026
Reconstruct Human Retinoblastoma In Vitro
Published on: October 11, 2022
Preserving vision in retinoblastoma through early detection and intervention
1Pediatric Oncology Department, Santa Marcelina Hospital, São Paulo, Brazil. epelman@inctrbrasil.org
Insights
Retinoblastoma, a common childhood eye cancer, requires early detection for effective treatment. Improving public and healthcare provider awareness of early signs like leukocoria can save more children's vision and lives.
Area of Science:
- Ophthalmology
- Pediatric Oncology
- Genetics
Background:
- Retinoblastoma is the most common primary eye neoplasm in children.
- It affects approximately 1 in 14,000 to 18,000 live births, with higher incidence in developing nations.
- Early detection is crucial for eye-sparing treatments and minimizing disease morbidity.
Purpose of the Study:
- To highlight the importance of early detection of retinoblastoma.
- To emphasize the need for increased public and healthcare provider awareness of early signs.
- To discuss the potential impact of improved awareness on diagnosis and treatment outcomes.
Main Methods:
- Literature review on retinoblastoma incidence, signs, and current therapeutic advances.
- Analysis of diagnostic delays attributed to lack of awareness.
- Discussion of the role of public health initiatives in early diagnosis.
Main Results:
- Leukocoria, often noticed by parents (especially in flash photography), is a key early sign.
- Diagnosis is frequently delayed due to insufficient awareness among healthcare providers and the public.
- Advances in basic science and clinical applications are improving treatment options.
Conclusions:
- Enhanced public and professional awareness of retinoblastoma's early signs is vital for timely diagnosis.
- Early diagnosis facilitates the use of eye-sparing treatments, improving outcomes.
- Widespread availability of conservative treatments is expected to increase cure rates and preserve vision in more children worldwide.
Abstract:
The most frequent neoplasm of the eye in children is retinoblastoma. It is a rare disease with an average incidence of 1 in 14,000 to 18,000 live births. The incidence is greater in developing countries. Early detection may allow widespread use of eye-sparing treatments, minimizing the morbidity of this disease. Although leukocoria is usually the first sign that parents notice especially when a flash photograph is taken, the diagnosis is not performed since this presentation is not known by health care providers and the public. Improving public awareness and knowledge of the early signs may lead to early diagnosis, which can save more eyes and lives. Advances in both the basic science and clinical applications of new therapies continue to emerge for this rare cancer. We expect that all conservative treatments will be available worldwide and consequently more children will be cured and maintain the vision.
Related Concept Videos
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:27Diabetic Retinopathy
01:27Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...